EMA approves Nuvaxovid from US-based Novavax as EU’s 5th Covid vaccine
Latest: Coronavirus in Spain figures (23 Dec) The European Medicines Agency (EMA) has approved the use of the Nuvaxovid vaccine against Covid-19 for people aged 18 years, developed
